EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 21 (2014) Parasite, 21 (2014) 38 References
Open Access
Review
Issue
Parasite
Volume 21, 2014
Article Number 38
Number of page(s) 9
DOI https://doi.org/10.1051/parasite/2014040
Published online 04 August 2014
  1. Afonso AM, Ebell MH, Tarleton RL. 2012. A systematic review of high quality diagnostic tests for Chagas disease. PLoS Neglected Tropical Diseases, 6(11), 1881. [CrossRef] [Google Scholar]
  2. Coelho dos Santos JS, Menezes CAS, Villani FNA, Magalhães LMD, Scharfstein J, Gollob JK, Dutra WO. 2010. Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells. Clinical & Experimental Immunology, 162(3), 528–536. [CrossRef] [Google Scholar]
  3. Cordova E, Maiolo E, Corti M, Orduna T. 2010. Neurological manifestations of Chagas’ disease. Neurological Research, 32(3), 238–244. [CrossRef] [PubMed] [Google Scholar]
  4. Coura JR, Borges-Pereira J. 2010. Chagas disease: 100 years after its discovery. A systemic review. Acta Tropica, 115(1–2), 5–13. [CrossRef] [PubMed] [Google Scholar]
  5. Dvorak JA, Howe CL. 1976. The attraction of Trypanosoma cruzi to vertebrate cells in vitro. Journal of Protozoology, 23(4), 534–537. [CrossRef] [Google Scholar]
  6. Dvorak JA, Poore CM. 1974. Trypanosoma cruzi, interaction with vertebrate cells in vitro. IV. Environmental temperature effects. Experimental Parasitology, 36(1), 150–157. [CrossRef] [PubMed] [Google Scholar]
  7. Epting CL, Coates BM, Engman DM. 2010. Molecular mechanisms of host cell invasion by Trypanosoma cruzi. Experimental Parasitology, 126(3), 283–291. [CrossRef] [PubMed] [Google Scholar]
  8. Faria LO, Lima BD, Martins de Sá C. 2008. Trypanosoma cruzi: Effect of the infection on the 20S proteasome in non-immune cells. Experimental Parasitology, 120(3), 261–268. [CrossRef] [PubMed] [Google Scholar]
  9. Giraldo NA, Bolaños NI, Cuellar A, Roa N, Cucunubá Z, Fernando Rosas, Victor Velasco, Puerta Concepcioón J, González John M. 2013. T lymphocytes from chagasic patients are activated but lack proliferative capacity and down-regulate CD28 and CD3ζ. PLoS Neglected Tropical Diseases, 7, e2038. [CrossRef] [PubMed] [Google Scholar]
  10. Guevara P, Dias M, Rojas A, Crisante G, Abreu-Blanco MT, Umezawa E, Vazquez M, Levin M, Añez N, Ramirez JL. 2005. Expression of fluorescent genes in Trypanosoma cruzi and Trypanosoma rangeli (Kinetoplastida, Trypanosomatidae): its application to parasite-vector biology. Journal of Medical Entomology, 42(1), 48–56. [CrossRef] [PubMed] [Google Scholar]
  11. Gutteridge WE, Knowler J, Coombs JD. 1969. Growth of Trypanosoma cruzi in human heart tissue cells and effects of aminonucleoside of puromycin, trypacidin and aminopterin. Journal of Protozoology, 16(3), 521–525. [CrossRef] [Google Scholar]
  12. Hassan GS, Mukherjee S, Nagajyothi F, Weiss LM, Petkova SB, de Almeida CJ, Huang H, Desruisseaux MS, Bouzahzah B, Pestell RG, Albanese C, Christ GJ, Lisanti MP, Tannowitz HP. 2006. Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infection and Immunity, 74(1), 152–159. [CrossRef] [PubMed] [Google Scholar]
  13. Hemmige V, Tanowitz H, Sethi A. 2012. Trypanosoma cruzi infection: a review with emphasis on cutaneous manifestations. International Journal of Dermatology, 51(5), 501–508. [CrossRef] [PubMed] [Google Scholar]
  14. Luban NA, Dvorak JA. 1974. Trypanosoma cruzi, Interaction with vertebrate cells in vitro: III. Selection for biological characteristics following intracellular passage. Experimental Parasitology, 36(1), 143–149. [CrossRef] [PubMed] [Google Scholar]
  15. Machado FS, Dutra WO, Esper L, Gollob KJ, Teixeira MM, Factor SM, Weiss LM, Nagajyothi F, Tanowitz HB, Garg NJ. 2012. Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Seminars in Immunopathology, 34(6), 753–770. [CrossRef] [PubMed] [Google Scholar]
  16. Morris SA, Tanowitz H, Hatcher V, Bilezikian JP, Wittner M. 1988. Alterations in intracellular calcium following infection of human endothelial cells with Trypanosoma cruzi. Molecular and Biochemical Parasitology, 29(2–3), 213–221. [CrossRef] [PubMed] [Google Scholar]
  17. Mukherjee S, Huang H, Petkova SB, Albanese C, Pestell RG, Braunstein VL, Christ GJ, Wittner M, Lisanti MP, Berman JW, Weiss LM, Tanowitz HB. 2004. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infection and Immunity, 72(9), 5274–5282. [CrossRef] [PubMed] [Google Scholar]
  18. Nogueira N, Cohn Z. 1976. Trypanosoma cruzi: mechanism of entry and intracellular fate in mammalian cells. Journal of Experimental Medicine, 143(6), 1402–1420. [CrossRef] [Google Scholar]
  19. Osuna A, Castanys S, Rodriguez-Cabezas MN, Gamarro F. 1990. Trypanosoma cruzi: calcium ion movement during internalization in host HeLa cells. International Journal of Parasitology, 20(5), 673–676. [CrossRef] [Google Scholar]
  20. Piras MM, Henríquez D, Piras R. 1987. The effect of fetuin and other sialoglycoproteins on the in vitro penetration of Trypanosoma cruzi trypomastigotes into fibroblastic cells. Molecular and Biochemical Parasitology, 22(2–3), 135–143. [CrossRef] [PubMed] [Google Scholar]
  21. Piras MM, Piras R, Henriquez D, Negri S. 1982. Changes in morphology and infectivity of cell culture-derived trypomastigotes of Trypanosoma cruzi. Molecular and Biochemical Parasitology, 6(2), 67–81. [CrossRef] [PubMed] [Google Scholar]
  22. Pires SF, DaRocha WD, Freitas JM, Oliveira LA, Kitten GT, Machado CR, Pena SDJ, Chiari E, Macedo AM, Teixeira SMR. 2008. Cell culture and animal infection with distinct Trypanosoma cruzi strains expressing red and green fluorescent proteins. International Journal of Parasitology, 38(3–4), 289–297. [CrossRef] [Google Scholar]
  23. Rassi A Jr, Rassi A, Marcondes de Rezende J. 2012. American Trypanosomiasis (Chagas Disease). Infectious Disease Clinics of North America, 26(2), 275–291. [CrossRef] [PubMed] [Google Scholar]
  24. Revollo S, Oury B, Laurent JP, Barnabé C, Quesney V, Carrière V, Noël S, Tibayrenc M. 1998. Trypanosoma cruzi: Impact of clonal evolution of the parasite on its biological and medical properties. Experimental Parasitology, 89(1), 30–39. [CrossRef] [PubMed] [Google Scholar]
  25. Sanderson CJ, Thomas JA, Twomey CE. 1980. The growth of Trypanosoma cruzi in human diploid cells for the production of trypomastigotes. Parasitology, 80(1), 153–162. [CrossRef] [PubMed] [Google Scholar]
  26. Sartori MJ, Mezzano L, Lin S, Muñoz S, De Fabro SP. 2003. Role of placental alkaline phosphatase in the internalization of trypomastigotes of Trypanosoma cruzi into HEp2 cells. Tropical Medicine & International Health, 8(9), 832–839. [CrossRef] [Google Scholar]
  27. Soares RO, Echevarria A, Bellieny MS, Pinho RT, de Leo RM, Seguins WS, Machado GM, Canto-Cavalheiro MM, Leon LL. 2011. Evaluation of thiosemicarbazones and semicarbazones as potential agents anti-Trypanosoma cruzi. Experimental Parasitology, 129(4), 381–387. [CrossRef] [PubMed] [Google Scholar]
  28. Souza PEA, Rocha MOC, Menezes CAS, Coelho JS, Chaves ACL, Gollob JK, Dutra WO. 2007. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas’ disease. Infection and Immunity, 75(4), 1886–1894. [CrossRef] [PubMed] [Google Scholar]
  29. Teixeira AR, Hecht MM, Guimaro MC, Sousa AO, Nitz N. 2011. Pathogenesis of Chagas’ disease: parasite persistence and autoimmunity. Clinical Microbiology Reviews, 24(3), 592–630. [CrossRef] [PubMed] [Google Scholar]
  30. Todorov AG, Andrade D, Pesquero JB, Araujo RC, Bader M, Stewart J, Gera L, Müller-Esterl W, Morandi V, Goldenberg RC, Neto HC, Scharfstein J. 2003. Trypanosoma cruzi induces edematogenic responses in mice and invades cardiomyocytes and endothelial cells in vitro by activating distinct kinin receptor (B1/B2) subtypes. FASEB Journal, 17(1), 73–75. [Google Scholar]
  31. Urbina JA, Lazardi K, Aguirre T, Piras MM, Piras R. 1988. Antiproliferative synergism of the allylamine SF 86–327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrobial Agents and Chemotherapy, 32(8), 1237–1242. [CrossRef] [PubMed] [Google Scholar]
  32. Urbina JA, Concepcion JL, Rangel S, Visbal G, Lira R. 2002. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana. Molecular and Biochemical Parasitology, 125(1–2), 35–45. [CrossRef] [PubMed] [Google Scholar]
  33. Vargas-Zambrano JC, Lasso P, Cuellar A, Puerta CJ, González JM. 2013. A human astrocytoma cell line is highly susceptible to infection with Trypanosoma cruzi. Memorias do Instituto Oswaldo Cruz, 108(2), 212–219. [CrossRef] [PubMed] [Google Scholar]
  34. Vilchez Larrea SC, Haikarainen T, Narwal M, Schlesinger M, Venkannagari H, Flawiá MM, Villamil SH, Lehtiö L. 2012. Inhibition of poly(ADP-ribose) Polymerase Interferes with Trypanosoma cruzi Infection and Proliferation of the Parasite. PLoS One, 7(9), e46063. [CrossRef] [PubMed] [Google Scholar]
  35. Williams DM, Remington JS. 1977. Effect of human monocytes and macrophages on Trypanosoma cruzi. Immunology, 32(1), 19–23. [PubMed] [Google Scholar]
  36. Wittner M, Christ GJ, Huang H, Weiss LM, Hatcher VB, Morris SA, Orr GA, Berman JW, Zeballos GA, Douglas SA. 1995. Trypanosoma cruzi induces endothelin release from endothelial cells. Journal of Infectious Diseases, 171(2), 493–497. [CrossRef] [Google Scholar]
  37. Yoshida N, Favoreto S Jr, Ferreira AT, Manque PM. 2000. Signal transduction induced in Trypanosoma cruzi metacyclic trypomastigotes during the invasion of mammalian cells. Brazilian Journal of Medical and Biological Research, 33(3), 269–278. [CrossRef] [Google Scholar]
  38. Zingales B, Andrade SG, Briones MRS, Campbell DA, Chiari E, Fernandes O, Guhl F, Lages-Silva E, Macedo AM, Machado CR, Miles MA, Romanha AJ, Sturm NR, Tibayrenc M, Schijman AG. 2009. A new consensus for Trypanosoma cruzi intraspecific nomenclature, second revision meeting recommends TcI to TcVI. Memorias do Instituto Oswaldo Cruz, 104(7), 1051–1054. [Google Scholar]
  39. Zingales B, Miles MA, Campbell DA, Tibayrenc M, Macedo AM, Teixeira MM, Schijman AG, Llewellyn MS, Lages-Silva E, Machado CR, Andrade SG, Sturm NR. 2012. The revised Trypanosoma cruzi subspecific nomenclature, rationale, epidemiological relevance and research applications. Infection, Genetics, and Evolution, 12(2), 240–253. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.